Authors

Manmeet Ahluwalia, Miami Cancer InstituteFollow

Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization

Publication Date

12-20-2023

Content Type

Article

PubMed ID:

37722087

Additional Authors:

Additional authors and institutional affiliations

Citation

Rahman, R., Trippa, L., Lee, E. Q., Arrillaga-Romany, I., Fell, G., Touat, M., McCluskey, C., Wiley, J., Gaffey, S., Drappatz, J., Welch, M. R., Galanis, E., Ahluwalia, M. S., Colman, H., Nabors, L. B., Hepel, J., Elinzano, H., Schiff, D., Chukwueke, U. N., Beroukhim, R., … Wen, P. Y. (2023). Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(36), 5524–5535. https://doi.org/10.1200/JCO.23.00493